{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T09:11:36Z","timestamp":1793610696524,"version":"4.5.0"},"reference-count":145,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.phrs.2021.105661","type":"journal-article","created":{"date-parts":[[2021,5,7]],"date-time":"2021-05-07T03:51:22Z","timestamp":1620359482000},"page":"105661","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":125,"special_numbering":"C","title":["Tanshinone IIA: A phytochemical as a promising drug candidate for neurodegenerative diseases"],"prefix":"10.1016","volume":"169","author":[{"given":"Lalita","family":"Subedi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9738-6493","authenticated-orcid":false,"given":"Bhakta Prasad","family":"Gaire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.phrs.2021.105661_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines8080284","article-title":"Neuroprotection: targeting multiple pathways by naturally occurring phytochemicals","volume":"8","author":"Khan","year":"2020","journal-title":"Biomedicines"},{"issue":"12","key":"10.1016\/j.phrs.2021.105661_bib2","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1007\/s00702-017-1797-5","article-title":"Neurotrophic function of phytochemicals for neuroprotection in aging and neurodegenerative disorders: modulation of intracellular signaling and gene expression","volume":"124","author":"Naoi","year":"2017","journal-title":"J. Neural Transm. (Vienna)"},{"issue":"12","key":"10.1016\/j.phrs.2021.105661_bib3","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1002\/ptr.1970","article-title":"Potential medicinal plants for CNS disorders: an overview","volume":"20","author":"Kumar","year":"2006","journal-title":"Phytother. Res."},{"issue":"3","key":"10.1016\/j.phrs.2021.105661_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21030764","article-title":"Phytochemicals against TNF\u03b1-mediated neuroinflammatory diseases","volume":"21","author":"Subedi","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.phrs.2021.105661_bib5","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s11655-018-2828-2","article-title":"Herbal medicine in ischemic stroke: challenges and prospective","volume":"24","author":"Gaire","year":"2018","journal-title":"Chin. J. Integr. Med."},{"issue":"10","key":"10.1016\/j.phrs.2021.105661_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23102485","article-title":"Neuroprotective Role of Phytochemicals","volume":"23","author":"Velmurugan","year":"2018","journal-title":"Molecules"},{"issue":"9","key":"10.1016\/j.phrs.2021.105661_bib7","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1007\/s11655-014-1347-9","article-title":"Scutellaria baicalensis in stroke management: nature\u2019s blessing in traditional Eastern medicine","volume":"20","author":"Gaire","year":"2014","journal-title":"Chin. J. Integr. Med"},{"key":"10.1016\/j.phrs.2021.105661_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105419","article-title":"Phytochemicals as regulators of microglia\/macrophages activation in cerebral ischemia","volume":"165","author":"Subedi","year":"2021","journal-title":"Pharm. Res."},{"key":"10.1016\/j.phrs.2021.105661_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173412","article-title":"Neuroprotective role of polyphenols against oxidative stress-mediated neurodegeneration","volume":"886","author":"Uddin","year":"2020","journal-title":"Eur. J. Pharm."},{"issue":"12","key":"10.1016\/j.phrs.2021.105661_bib10","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1177\/0091270005282630","article-title":"Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use","volume":"45","author":"Zhou","year":"2005","journal-title":"J. Clin. Pharm."},{"issue":"12","key":"10.1016\/j.phrs.2021.105661_bib11","first-page":"1089","article-title":"Salvia miltiorrhiza and ischemic diseases","volume":"21","author":"Ji","year":"2000","journal-title":"Acta Pharm. Sin."},{"key":"10.1016\/j.phrs.2021.105661_bib12","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3389\/fphar.2019.00202","article-title":"Tanshinones, critical pharmacological components in salvia miltiorrhiza","volume":"10","author":"Jiang","year":"2019","journal-title":"Front Pharm."},{"key":"10.1016\/j.phrs.2021.105661_bib13","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/bs.apha.2019.10.001","article-title":"Pharmacological properties of tanshinones, the natural products from Salvia miltiorrhiza","volume":"87","author":"Wang","year":"2020","journal-title":"Adv. Pharm."},{"issue":"10","key":"10.1016\/j.phrs.2021.105661_bib14","doi-asserted-by":"crossref","first-page":"13621","DOI":"10.3390\/ijms131013621","article-title":"Tanshinones: sources, pharmacokinetics and anti-cancer activities","volume":"13","author":"Zhang","year":"2012","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2021.105661_bib15","first-page":"121","article-title":"Recent insights into the biological activities and drug delivery systems of tanshinones","volume":"11","author":"Cai","year":"2016","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.phrs.2021.105661_bib16","doi-asserted-by":"crossref","first-page":"4735","DOI":"10.2147\/DDDT.S266911","article-title":"Pharmacological activity and mechanism of tanshinone IIA in related diseases","volume":"14","author":"Guo","year":"2020","journal-title":"Drug Des. Dev. Ther."},{"issue":"3","key":"10.1016\/j.phrs.2021.105661_bib17","first-page":"163","article-title":"Salvia miltiorrhiza: traditional medicinal uses, chemistry, and pharmacology","volume":"13","author":"Su","year":"2015","journal-title":"Chin. J. Nat. Med."},{"issue":"14","key":"10.1016\/j.phrs.2021.105661_bib18","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1055\/s-2006-951698","article-title":"Pharmacokinetics, absorption and tissue distribution of tanshinone IIA solid dispersion","volume":"72","author":"Hao","year":"2006","journal-title":"Planta Med."},{"issue":"2","key":"10.1016\/j.phrs.2021.105661_bib19","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/01.WCB.0000111614.19196.04","article-title":"Pathophysiology of cerebral ischemia and brain trauma: similarities and differences","volume":"24","author":"Bramlett","year":"2004","journal-title":"J. Cereb. Blood Flow. Metab."},{"issue":"1","key":"10.1016\/j.phrs.2021.105661_bib20","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s12974-019-1516-2","article-title":"Neuroinflammation: friend and foe for ischemic stroke","volume":"16","author":"Jayaraj","year":"2019","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.phrs.2021.105661_bib21","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s12017-020-08614-2","article-title":"Sphingosine 1-phosphate receptors in cerebral ischemia","volume":"23","author":"Gaire","year":"2021","journal-title":"Neuromol. Med."},{"key":"10.1016\/j.phrs.2021.105661_bib22","doi-asserted-by":"crossref","first-page":"522","DOI":"10.4062\/biomolther.2019.005","article-title":"S1P1 Regulates M1\/M2 Polarization toward Brain Injury after Transient Focal Cerebral Ischemia","author":"Gaire","year":"2019","journal-title":"Biomol. Ther. (Seoul)"},{"issue":"1","key":"10.1016\/j.phrs.2021.105661_bib23","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s12974-019-1555-8","article-title":"Lysophosphatidic acid receptor 1 (LPA1) plays critical roles in microglial activation and brain damage after transient focal cerebral ischemia","volume":"16","author":"Gaire","year":"2019","journal-title":"J. Neuroinflamm."},{"issue":"1","key":"10.1016\/j.phrs.2021.105661_bib24","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1186\/s12974-018-1323-1","article-title":"Sphingosine 1-phosphate receptor subtype 3 (S1P3) contributes to brain injury after transient focal cerebral ischemia via modulating microglial activation and their M1 polarization","volume":"15","author":"Gaire","year":"2018","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.phrs.2021.105661_bib25","doi-asserted-by":"crossref","first-page":"488","DOI":"10.3389\/fncel.2018.00488","article-title":"Microglia in neurological diseases: a road map to brain-disease dependent-inflammatory response","volume":"12","author":"Bachiller","year":"2018","journal-title":"Front. Cell Neurosci."},{"issue":"2","key":"10.1016\/j.phrs.2021.105661_bib26","doi-asserted-by":"crossref","first-page":"176","DOI":"10.5114\/fn.2020.96983","article-title":"Tanshinone IIA alleviates the damage of neurocytes by targeting GLUT1 in ischaemia reperfusion model (in vivo and in vitro experiments)","volume":"58","author":"Wang","year":"2020","journal-title":"Folia Neuropathol."},{"key":"10.1016\/j.phrs.2021.105661_bib27","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.neuroscience.2020.05.054","article-title":"Sodium tanshinone IIA sulfonate protects against cerebral ischemia-reperfusion injury by inhibiting autophagy and inflammation","volume":"441","author":"Wang","year":"2020","journal-title":"Neuroscience"},{"issue":"4","key":"10.1016\/j.phrs.2021.105661_bib28","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1078\/094471103322004776","article-title":"Neuroprotective effects of tanshinones in transient focal cerebral ischemia in mice","volume":"10","author":"Lam","year":"2003","journal-title":"Phytomedicine"},{"issue":"4","key":"10.1016\/j.phrs.2021.105661_bib29","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1089\/rej.2016.1912","article-title":"Tanshinone IIA elicits neuroprotective effect through activating the nuclear factor erythroid 2-related factor-dependent antioxidant response","volume":"20","author":"Cai","year":"2017","journal-title":"Rejuvenation Res."},{"key":"10.1016\/j.phrs.2021.105661_bib30","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jep.2016.02.022","article-title":"Protective effect of Naoxintong against cerebral ischemia reperfusion injury in mice","volume":"182","author":"Xue","year":"2016","journal-title":"J. Ethnopharmacol."},{"issue":"2","key":"10.1016\/j.phrs.2021.105661_bib31","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1177\/0394632017703274","article-title":"Tanshinone inhibits neuronal cell apoptosis and inflammatory response in cerebral infarction rat model","volume":"30","author":"Zhou","year":"2017","journal-title":"Int. J. Immunopathol. Pharm."},{"issue":"6","key":"10.1016\/j.phrs.2021.105661_bib32","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/WNR.0000000000000559","article-title":"Tanshinone IIA increases levels of NeuN, protein disulfide isomerase, and Na+\/K+-ATPase and decreases evidence of microglial activation after cerebral ischemic injury","volume":"27","author":"Wen","year":"2016","journal-title":"Neuroreport"},{"issue":"41","key":"10.1016\/j.phrs.2021.105661_bib33","doi-asserted-by":"crossref","first-page":"69","DOI":"10.4103\/0973-1296.149706","article-title":"Studies on the active constituents in radix salviae miltiorrhizae and their protective effects on cerebral ischemia reperfusion injury and its mechanism","volume":"11","author":"Li","year":"2015","journal-title":"Pharm. Mag."},{"key":"10.1016\/j.phrs.2021.105661_bib34","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.neuroscience.2014.12.028","article-title":"Tanshinone IIA attenuates the cerebral ischemic injury-induced increase in levels of GFAP and of caspases-3 and -8","volume":"288","author":"Zhou","year":"2015","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/j.phrs.2021.105661_bib35","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s11064-013-1221-y","article-title":"Protective effect of Tanshinone IIA against infarct size and increased HMGB1, NFkappaB, GFAP and apoptosis consequent to transient middle cerebral artery occlusion","volume":"39","author":"Wang","year":"2014","journal-title":"Neurochem. Res."},{"issue":"28","key":"10.1016\/j.phrs.2021.105661_bib36","doi-asserted-by":"crossref","first-page":"6893","DOI":"10.1016\/j.biomaterials.2013.05.021","article-title":"The effect of cationic albumin-conjugated PEGylated tanshinone IIA nanoparticles on neuronal signal pathways and neuroprotection in cerebral ischemia","volume":"34","author":"Liu","year":"2013","journal-title":"Biomaterials"},{"issue":"10","key":"10.1016\/j.phrs.2021.105661_bib37","first-page":"1628","article-title":"Study on regulation of tanshinone II(A) on GFAP and ATPase and PDI of cerebral ischemia reperfusion injury in rats","volume":"35","author":"Wen","year":"2012","journal-title":"Zhong Yao Cai"},{"issue":"8","key":"10.1016\/j.phrs.2021.105661_bib38","first-page":"1073","article-title":"Effects of sodium tanshinone B on the protein expression of NMDAR1 in rat hippocampal subfields following focal ischemia\/reperfusion injury","volume":"32","author":"Cai","year":"2012","journal-title":"Zhongguo Zhong Xi Yi Jie He Za Zhi"},{"issue":"11","key":"10.1016\/j.phrs.2021.105661_bib39","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s11655-012-1266-9","article-title":"Neutroprotective efficacy of sodium tanshinone B on hippocampus neuron in a rat model of focal cerebral ischemia","volume":"18","author":"Cai","year":"2012","journal-title":"Chin. J. Integr. Med"},{"issue":"3","key":"10.1016\/j.phrs.2021.105661_bib40","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.biomaterials.2012.10.017","article-title":"Protective effects of cationic bovine serum albumin-conjugated PEGylated tanshinone IIA nanoparticles on cerebral ischemia","volume":"34","author":"Liu","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.phrs.2021.105661_bib41","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.brainres.2012.09.034","article-title":"Neuroprotective effects of tanshinone IIA and\/or tetramethylpyrazine in cerebral ischemic injury in vivo and in vitro","volume":"1488","author":"Tang","year":"2012","journal-title":"Brain Res."},{"issue":"2","key":"10.1016\/j.phrs.2021.105661_bib42","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1248\/bpb.35.164","article-title":"Neuroprotective capabilities of Tanshinone IIA against cerebral ischemia\/reperfusion injury via anti-apoptotic pathway in rats","volume":"35","author":"Chen","year":"2012","journal-title":"Biol. Pharm. Bull."},{"issue":"3","key":"10.1016\/j.phrs.2021.105661_bib43","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.neulet.2007.02.079","article-title":"Tanshinone IIB, a primary active constituent from Salvia miltiorrhza, exhibits neuro-protective activity in experimentally stroked rats","volume":"417","author":"Yu","year":"2007","journal-title":"Neurosci. Lett."},{"issue":"6","key":"10.1016\/j.phrs.2021.105661_bib44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0040165","article-title":"Neuroprotection of tanshinone IIA against cerebral ischemia\/reperfusion injury through inhibition of macrophage migration inhibitory factor in rats","volume":"7","author":"Chen","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.phrs.2021.105661_bib45","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1159\/000325202","article-title":"Tanshinone IIA prevented brain iron dyshomeostasis in cerebral ischemic rats","volume":"27","author":"Yang","year":"2011","journal-title":"Cell Physiol. Biochem."},{"issue":"14","key":"10.1016\/j.phrs.2021.105661_bib46","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.phymed.2010.03.017","article-title":"The effects of Tanshinone IIA on blood-brain barrier and brain edema after transient middle cerebral artery occlusion in rats","volume":"17","author":"Tang","year":"2010","journal-title":"Phytomedicine"},{"issue":"5","key":"10.1016\/j.phrs.2021.105661_bib47","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.3892\/etm.2014.1936","article-title":"Protective effect of tanshinone IIA on the brain and its therapeutic time window in rat models of cerebral ischemia-reperfusion","volume":"8","author":"Tang","year":"2014","journal-title":"Exp. Ther. Med"},{"issue":"3\u20134","key":"10.1016\/j.phrs.2021.105661_bib48","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.brainresbull.2010.04.005","article-title":"The neuroprotective effects of Tanshinone IIA are associated with induced nuclear translocation of TORC1 and upregulated expression of TORC1, pCREB and BDNF in the acute stage of ischemic stroke","volume":"82","author":"Liu","year":"2010","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.phrs.2021.105661_bib49","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.2147\/DDDT.S253280","article-title":"Tanshinone IIA promotes axonal regeneration in rats with focal cerebral ischemia through the inhibition of Nogo-A\/NgR1\/RhoA\/ROCKII\/MLC signaling","volume":"14","author":"Wang","year":"2020","journal-title":"Drug Des. Devel Ther."},{"key":"10.1016\/j.phrs.2021.105661_bib50","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.brainres.2009.12.046","article-title":"Tanshinone II A down-regulates HMGB1, RAGE, TLR4, NF-kappaB expression, ameliorates BBB permeability and endothelial cell function, and protects rat brains against focal ischemia","volume":"1321","author":"Wang","year":"2010","journal-title":"Brain Res."},{"issue":"5","key":"10.1016\/j.phrs.2021.105661_bib51","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/ptr.2615","article-title":"Neuroprotective effects of Tanshinone IIA on permanent focal cerebral ischemia in mice","volume":"23","author":"Dong","year":"2009","journal-title":"Phytother. Res."},{"key":"10.1016\/j.phrs.2021.105661_bib52","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jep.2017.06.023","article-title":"Salvia miltiorrhiza Bunge (Danshen) extract attenuates permanent cerebral ischemia through inhibiting platelet activation in rats","volume":"207","author":"Fei","year":"2017","journal-title":"J. Ethnopharmacol."},{"issue":"7","key":"10.1016\/j.phrs.2021.105661_bib53","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1007\/s11064-014-1312-4","article-title":"Anti-inflammatory effect of tanshinone I in neuroprotection against cerebral ischemia-reperfusion injury in the gerbil hippocampus","volume":"39","author":"Park","year":"2014","journal-title":"Neurochem. Res."},{"issue":"19","key":"10.1016\/j.phrs.2021.105661_bib54","first-page":"3396","article-title":"Neuroprotection via maintenance or increase of antioxidants and neurotrophic factors in ischemic gerbil hippocampus treated with tanshinone I","volume":"127","author":"Park","year":"2014","journal-title":"Chin. Med. J. (Engl.)"},{"issue":"8","key":"10.1016\/j.phrs.2021.105661_bib55","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1016\/j.fitote.2012.09.020","article-title":"Comparison of neuroprotective effects of five major lipophilic diterpenoids from Danshen extract against experimentally induced transient cerebral ischemic damage","volume":"83","author":"Park","year":"2012","journal-title":"Fitoterapia"},{"issue":"14","key":"10.1016\/j.phrs.2021.105661_bib56","first-page":"1883","article-title":"Neuroprotective effects of tanshinone II A on vascular dementia in rats","volume":"35","author":"He","year":"2010","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"issue":"2","key":"10.1016\/j.phrs.2021.105661_bib57","first-page":"1899","article-title":"Tanshinone IIA improves hypoxic ischemic encephalopathy through TLR4mediated NFkappaB signal pathway","volume":"18","author":"Fang","year":"2018","journal-title":"Mol. Med. Rep."},{"issue":"3","key":"10.1016\/j.phrs.2021.105661_bib58","doi-asserted-by":"crossref","first-page":"183","DOI":"10.5115\/acb.2013.46.3.183","article-title":"Neuroprotective effects of tanshinone I from Danshen extract in a mouse model of hypoxia-ischemia","volume":"46","author":"Lee","year":"2013","journal-title":"Anat. Cell Biol."},{"issue":"1","key":"10.1016\/j.phrs.2021.105661_bib59","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13041-017-0332-9","article-title":"Tanshinone I alleviates motor and cognitive impairments via suppressing oxidative stress in the neonatal rats after hypoxic-ischemic brain damage","volume":"10","author":"Dai","year":"2017","journal-title":"Mol. Brain"},{"issue":"12","key":"10.1016\/j.phrs.2021.105661_bib60","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1002\/ptr.3500","article-title":"Tanshinone IIa alleviates the biochemical changes associated with hypoxic ischemic brain damage in a rat model","volume":"25","author":"Hei","year":"2011","journal-title":"Phytother. Res."},{"issue":"9","key":"10.1016\/j.phrs.2021.105661_bib61","first-page":"940","article-title":"Effect of Tanshinone IIA on phosphorylated NMDA receptor 1 expression and intracellular free calcium concentration in neonatal SD rats with hypoxic ischemic brain damage","volume":"35","author":"Hei","year":"2010","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban."},{"issue":"4","key":"10.1016\/j.phrs.2021.105661_bib62","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1203\/01.PDR.0000180550.99162.BC","article-title":"Partial neuroprotective effect of pretreatment with tanshinone IIA on neonatal hypoxia-ischemia brain damage","volume":"58","author":"Xia","year":"2005","journal-title":"Pedia Res."},{"issue":"36","key":"10.1016\/j.phrs.2021.105661_bib63","first-page":"2882","article-title":"Influence of tanshinone IIa on heat shock protein 70, Bcl-2 and bax expression in rats with spinal ischemia\/reperfusion injury","volume":"7","author":"Zhang","year":"2012","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.phrs.2021.105661_bib64","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.551745","article-title":"Mechanism study of the protective effects of sodium tanshinone IIA sulfonate against atorvastatin-induced cerebral hemorrhage in zebrafish: transcriptome analysis","volume":"11","author":"Zhou","year":"2020","journal-title":"Front Pharm."},{"issue":"2","key":"10.1016\/j.phrs.2021.105661_bib65","doi-asserted-by":"crossref","first-page":"132","DOI":"10.2174\/1567202614666170306105315","article-title":"Tanshinone IIA protects hippocampal neuronal cells from reactive oxygen species through changes in autophagy and activation of phosphatidylinositol 3-Kinase, protein kinas B, and mechanistic target of rapamycin pathways","volume":"14","author":"Zhu","year":"2017","journal-title":"Curr. Neurovasc. Res."},{"key":"10.1016\/j.phrs.2021.105661_bib66","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ejphar.2019.04.030","article-title":"Tanshinone IIA protects hypoxia-induced injury by preventing microRNA-28 up-regulation in PC-12 cells","volume":"854","author":"Tang","year":"2019","journal-title":"Eur. J. Pharm."},{"issue":"1","key":"10.1016\/j.phrs.2021.105661_bib67","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/00019052-200102000-00014","article-title":"Cerebral ischemia and inflammation","volume":"14","author":"Iadecola","year":"2001","journal-title":"Curr. Opin. Neurol."},{"issue":"1","key":"10.1016\/j.phrs.2021.105661_bib68","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nrn2038","article-title":"Microglia-mediated neurotoxicity: uncovering the molecular mechanisms","volume":"8","author":"Block","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"issue":"4","key":"10.1016\/j.phrs.2021.105661_bib69","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.nurt.2010.07.005","article-title":"Microglial activation in stroke: therapeutic targets","volume":"7","author":"Yenari","year":"2010","journal-title":"Neurotherapeutics"},{"issue":"11","key":"10.1016\/j.phrs.2021.105661_bib70","article-title":"BMS-986020, a Specific LPA1 antagonist, provides neuroprotection against ischemic stroke in mice","volume":"9","author":"Gaire","year":"2020","journal-title":"Antioxid. (Basel)"},{"issue":"2","key":"10.1016\/j.phrs.2021.105661_bib71","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0171479","article-title":"Eupatilin exerts neuroprotective effects in mice with transient focal cerebral ischemia by reducing microglial activation","volume":"12","author":"Sapkota","year":"2017","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.phrs.2021.105661_bib72","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0120203","article-title":"Neuroprotective effect of 6-paradol in focal cerebral ischemia involves the attenuation of neuroinflammatory responses in activated microglia","volume":"10","author":"Gaire","year":"2015","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.phrs.2021.105661_bib73","first-page":"660","article-title":"The protective effect of tanshinone IIA on oxygen-glucose deprivation and reperfusion injury of microgliathrough the NLRP3 inflammatory signaling pathway","volume":"47","author":"Cai","year":"2016","journal-title":"Sichuan Da Xue Xue Bao Yi Xue Ban."},{"issue":"1\u20132","key":"10.1016\/j.phrs.2021.105661_bib74","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.lfs.2014.07.020","article-title":"Tanshinone IIA dampens the cell proliferation induced by ischemic insult in rat astrocytes via blocking the activation of HIF-1alpha\/SDF-1 signaling","volume":"112","author":"Huang","year":"2014","journal-title":"Life Sci."},{"issue":"4","key":"10.1016\/j.phrs.2021.105661_bib75","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s12975-017-0526-6","article-title":"Sodium tanshinone IIA sulfonate enhances effectiveness Rt-PA treatment in acute ischemic stroke patients associated with ameliorating blood-brain barrier damage","volume":"8","author":"Ji","year":"2017","journal-title":"Transl. Stroke Res."},{"issue":"1\u20133","key":"10.1016\/j.phrs.2021.105661_bib76","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ejphar.2010.08.040","article-title":"Tanshinone IIA protects the human blood-brain barrier model from leukocyte-associated hypoxia-reoxygenation injury","volume":"648","author":"Zhang","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phrs.2021.105661_bib77","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/4517486","article-title":"Tanshinone IIA inhibits glutamate-induced oxidative toxicity through prevention of mitochondrial dysfunction and suppression of MAPK Activation in SH-SY5Y human neuroblastoma cells","volume":"2017","author":"Li","year":"2017","journal-title":"Oxid. Med. Cell Longev."},{"key":"10.1016\/j.phrs.2021.105661_bib78","doi-asserted-by":"crossref","first-page":"5541","DOI":"10.2147\/IJN.S200490","article-title":"Alzheimer\u2019s disease: pathogenesis, diagnostics, and therapeutics","volume":"14","author":"Tiwari","year":"2019","journal-title":"Int. J. Nanomed."},{"issue":"2","key":"10.1016\/j.phrs.2021.105661_bib79","doi-asserted-by":"crossref","first-page":"156","DOI":"10.2174\/187152710791012071","article-title":"Microglia and inflammation in Alzheimer\u2019s disease","volume":"9","author":"Mandrekar-Colucci","year":"2010","journal-title":"CNS Neurol. Disord. Drug Targets"},{"issue":"10","key":"10.1016\/j.phrs.2021.105661_bib80","doi-asserted-by":"crossref","first-page":"8071","DOI":"10.1007\/s12035-016-0297-1","article-title":"Inflammatory response in the CNS: friend or foe?","volume":"54","author":"Sochocka","year":"2017","journal-title":"Mol. Neurobiol."},{"issue":"3","key":"10.1016\/j.phrs.2021.105661_bib81","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18030504","article-title":"The diverse roles of microglia in the neurodegenerative aspects of central nervous system (CNS) autoimmunity","volume":"18","author":"Thompson","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.phrs.2021.105661_bib82","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","article-title":"Neuroinflammation in Alzheimer\u2019s disease","volume":"14","author":"Heneka","year":"2015","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.phrs.2021.105661_bib83","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2174\/1570159X13666150716165726","article-title":"Alzheimer\u2019s disease: targeting the Cholinergic System","volume":"14","author":"Ferreira-Vieira","year":"2016","journal-title":"Curr. Neuropharmacol."},{"issue":"2","key":"10.1016\/j.phrs.2021.105661_bib84","first-page":"187","article-title":"Selective in-vitro enzymes\u2019 inhibitory activities of fingerprints compounds of salvia species and molecular docking simulations","volume":"19","author":"Kocakaya","year":"2020","journal-title":"Iran. J. Pharm. Res."},{"issue":"12","key":"10.1016\/j.phrs.2021.105661_bib85","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21124475","article-title":"Norditerpenoids with Selective Anti-Cholinesterase Activity from the Roots of Perovskia atriplicifolia Benth","volume":"21","author":"Slusarczyk","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.phrs.2021.105661_bib86","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1186\/s12974-020-01981-4","article-title":"Tanshinone IIA attenuates neuroinflammation via inhibiting RAGE\/NF-\u03baB signaling pathway in vivo and in vitro","volume":"17","author":"Ding","year":"2020","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.phrs.2021.105661_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2019.104610","article-title":"Tanshinone IIA ameliorates cognitive deficits by inhibiting endoplasmic reticulum stress-induced apoptosis in APP\/PS1 transgenic mice","volume":"133","author":"He","year":"2020","journal-title":"Neurochem Int"},{"key":"10.1016\/j.phrs.2021.105661_bib88","article-title":"Tanshinone IIA alleviates the AD phenotypes in APP and PS1 transgenic mice","volume":"2016","author":"Li","year":"2016","journal-title":"Biomed. Res. Int."},{"issue":"7","key":"10.1016\/j.phrs.2021.105661_bib89","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1021\/acs.jafc.9b07022","article-title":"Specific degradation of endogenous tau protein and inhibition of tau fibrillation by tanshinone IIA through the ubiquitin-proteasome pathway","volume":"68","author":"Cai","year":"2020","journal-title":"J. Agric. Food Chem."},{"issue":"3","key":"10.1016\/j.phrs.2021.105661_bib90","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1177\/0891988719837373","article-title":"Tanshinone IIA ameliorates spatial learning and memory deficits by inhibiting the activity of ERK and GSK-3beta","volume":"32","author":"Lin","year":"2019","journal-title":"J. Geriatr. Psychiatry Neurol."},{"issue":"12","key":"10.1016\/j.phrs.2021.105661_bib91","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1097\/WNR.0000000000000618","article-title":"Tanshinone IIA decreases the levels of inflammation induced by Abeta1-42 in brain tissues of Alzheimer\u2019s disease model rats","volume":"27","author":"Lu","year":"2016","journal-title":"Neuroreport"},{"issue":"11","key":"10.1016\/j.phrs.2021.105661_bib92","first-page":"1210","article-title":"Effects of tanshinone IIA on the expressions of p53, pp53 and apoptosis in the rats with Alzheimer\u2019s disease","volume":"40","author":"Li","year":"2015","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban."},{"issue":"13","key":"10.1016\/j.phrs.2021.105661_bib93","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1097\/WNR.0000000000000419","article-title":"Upregulation effects of Tanshinone IIA on the expressions of NeuN, Nissl body, and IkappaB and downregulation effects on the expressions of GFAP and NF-kappaB in the brain tissues of rat models of Alzheimer\u2019s disease","volume":"26","author":"Li","year":"2015","journal-title":"Neuroreport"},{"issue":"2","key":"10.1016\/j.phrs.2021.105661_bib94","doi-asserted-by":"crossref","first-page":"689","DOI":"10.3892\/mmr.2014.2254","article-title":"Tanshinone IIA reduces the risk of Alzheimer\u2019s disease by inhibiting iNOS, MMP2 and NFkappaBp65 transcription and translation in the temporal lobes of rat models of Alzheimer\u2019s disease","volume":"10","author":"Jiang","year":"2014","journal-title":"Mol. Med. Rep."},{"issue":"2","key":"10.1016\/j.phrs.2021.105661_bib95","first-page":"155","article-title":"Effects of tanshinone IIA on the expressions of caspase-3, Akt and NF-kappaB in the brains of rat models of Alzheimer\u2019s disease","volume":"30","author":"Wen","year":"2014","journal-title":"Xi Bao Yu Fen. Zi Mian Yi Xue Za Zhi"},{"issue":"5","key":"10.1016\/j.phrs.2021.105661_bib96","doi-asserted-by":"crossref","first-page":"E248","DOI":"10.25011\/cim.v31i5.4871","article-title":"Effect of tanshinone on the levels of nitric oxide synthase and acetylcholinesterase in the brain of Alzheimer\u2019s disease rat model","volume":"31","author":"Yin","year":"2008","journal-title":"Clin. Invest. Med."},{"key":"10.1016\/j.phrs.2021.105661_bib97","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.bbr.2019.03.001","article-title":"Neuroprotective effect of tanshinone IIA-incubated mesenchymal stem cells on Abeta25-35-induced neuroinflammation","volume":"365","author":"Huang","year":"2019","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.phrs.2021.105661_bib98","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ijbiomac.2020.02.040","article-title":"Sodium tanshinone IIA sulfonate protects against Abeta1-42-induced cellular toxicity by modulating Abeta-degrading enzymes in HT22 cells","volume":"151","author":"Liu","year":"2020","journal-title":"Int J. Biol. Macromol."},{"issue":"7\u20138","key":"10.1016\/j.phrs.2021.105661_bib99","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.neuropharm.2010.08.013","article-title":"The neuroprotective effects of tanshinone IIA on beta-amyloid-induced toxicity in rat cortical neurons","volume":"59","author":"Liu","year":"2010","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.phrs.2021.105661_bib100","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.neuint.2012.04.019","article-title":"The protective effects of tanshinone IIA on neurotoxicity induced by beta-amyloid protein through calpain and the p35\/Cdk5 pathway in primary cortical neurons","volume":"61","author":"Shi","year":"2012","journal-title":"Neurochem. Int."},{"issue":"4","key":"10.1016\/j.phrs.2021.105661_bib101","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.brainresbull.2012.03.007","article-title":"The protective effects of tanshinone IIA on beta-amyloid protein (1-42)-induced cytotoxicity via activation of the Bcl-xL pathway in neuron","volume":"88","author":"Qian","year":"2012","journal-title":"Brain Res. Bull."},{"issue":"6","key":"10.1016\/j.phrs.2021.105661_bib102","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.1111\/jcmm.15006","article-title":"Sodium tanshinone IIA sulfonate protects against Abeta-induced cell toxicity through regulating Abeta process","volume":"24","author":"Zhang","year":"2020","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.phrs.2021.105661_bib103","first-page":"15","article-title":"Tanshinone IIA attenuates A\u03b2-induced neurotoxicity by down-regulating COX-2 expression and PGE2 synthesis via inactivation of NF-\u03baB pathway in SH-SY5Y cells","volume":"26","author":"Geng","year":"2019","journal-title":"J. Biol. Res."},{"key":"10.1016\/j.phrs.2021.105661_bib104","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.biocel.2018.12.011","article-title":"Protective effects of tanshinone IIA on SH-SY5Y cells against oAbeta1-42-induced apoptosis due to prevention of endoplasmic reticulum stress","volume":"107","author":"Yang","year":"2019","journal-title":"Int J. Biochem. Cell Biol."},{"issue":"6","key":"10.1016\/j.phrs.2021.105661_bib105","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1021\/cn400051e","article-title":"Tanshinones inhibit amyloid aggregation by amyloid-beta peptide, disaggregate amyloid fibrils, and protect cultured cells","volume":"4","author":"Wang","year":"2013","journal-title":"ACS Chem. Neurosci."},{"issue":"3","key":"10.1016\/j.phrs.2021.105661_bib106","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.etap.2011.02.006","article-title":"In Salvia miltiorrhiza, phenolic acids possess protective properties against amyloid beta-induced cytotoxicity, and tanshinones act as acetylcholinesterase inhibitors","volume":"31","author":"Zhou","year":"2011","journal-title":"Environ. Toxicol. Pharm."},{"issue":"6","key":"10.1016\/j.phrs.2021.105661_bib107","doi-asserted-by":"crossref","first-page":"6495","DOI":"10.1007\/s11033-012-1477-3","article-title":"Tanshinone IIA protects PC12 cells from beta-amyloid(25-35)-induced apoptosis via PI3K\/Akt signaling pathway","volume":"39","author":"Dong","year":"2012","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.phrs.2021.105661_bib108","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.phrs.2017.11.018","article-title":"Down regulation of pro-inflammatory pathways by tanshinone IIA and cryptotanshinone in a non-genetic mouse model of Alzheimer\u2019s disease","volume":"129","author":"Maione","year":"2018","journal-title":"Pharm. Res."},{"key":"10.1016\/j.phrs.2021.105661_bib109","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.neulet.2016.11.024","article-title":"Synergistic effect of tanshinone IIA and mesenchymal stem cells on preventing learning and memory deficits via anti-apoptosis, attenuating tau phosphorylation and enhancing the activity of central cholinergic system in vascular dementia","volume":"637","author":"Kong","year":"2017","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.phrs.2021.105661_bib110","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/9852536","article-title":"Sodium tanshinone IIA sulfonate attenuates scopolamine-induced cognitive dysfunctions via improving cholinergic system","volume":"2016","author":"Xu","year":"2016","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.phrs.2021.105661_bib111","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.brainres.2015.11.040","article-title":"Treatment effects of tanshinone IIA against intracerebroventricular streptozotocin induced memory deficits in mice","volume":"1631","author":"Liu","year":"2016","journal-title":"Brain Res."},{"key":"10.1016\/j.phrs.2021.105661_bib112","series-title":"Parkinson's Disease: Pathogenesis and Clinical Aspects","article-title":"Parkinson's Disease: Etiology, Neuropathology, and Pathogenesis","author":"Kouli","year":"2018"},{"issue":"10","key":"10.1016\/j.phrs.2021.105661_bib113","first-page":"860","article-title":"Etiopathogenesis and treatment of Parkinson\u2019s disease","volume":"9","author":"Gallagher","year":"2009","journal-title":"Curr. Top. Med Chem."},{"issue":"4","key":"10.1016\/j.phrs.2021.105661_bib114","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1136\/jnnp-2011-301205","article-title":"Molecular pathogenesis of Parkinson\u2019s disease: update","volume":"83","author":"Saiki","year":"2012","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"Suppl 1","key":"10.1016\/j.phrs.2021.105661_bib115","doi-asserted-by":"crossref","first-page":"S210","DOI":"10.1016\/S1353-8020(11)70065-7","article-title":"Neuroinflammation in Parkinson\u2019s disease","volume":"18","author":"Hirsch","year":"2012","journal-title":"Park. Relat. Disord."},{"issue":"3","key":"10.1016\/j.phrs.2021.105661_bib116","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.nbd.2009.11.004","article-title":"Neuroinflammation in Parkinson\u2019s disease: its role in neuronal death and implications for therapeutic intervention","volume":"37","author":"Tansey","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.phrs.2021.105661_bib117","first-page":"860","article-title":"Outside","volume":"9","author":"Troncoso-Escudero","year":"2018"},{"issue":"1","key":"10.1016\/j.phrs.2021.105661_bib118","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.it.2009.09.003","article-title":"T cell-microglial dialogue in Parkinson\u2019s disease and amyotrophic lateral sclerosis: are we listening?","volume":"31","author":"Appel","year":"2010","journal-title":"Trends Immunol."},{"issue":"4","key":"10.1016\/j.phrs.2021.105661_bib119","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/emm.2006.40","article-title":"Microglia, major player in the brain inflammation: their roles in the pathogenesis of Parkinson\u2019s disease","volume":"38","author":"Kim","year":"2006","journal-title":"Exp. Mol. Med."},{"issue":"1","key":"10.1016\/j.phrs.2021.105661_bib120","doi-asserted-by":"crossref","first-page":"65","DOI":"10.4103\/0976-3147.143197","article-title":"Psychiatric aspects of Parkinson\u2019s disease","volume":"6","author":"Grover","year":"2015","journal-title":"J. Neurosci. Rural Pr."},{"issue":"3","key":"10.1016\/j.phrs.2021.105661_bib121","first-page":"659","article-title":"Neuropsychiatric symptoms in parkinson\u2019s disease","volume":"5","author":"Aarsland","year":"2015","journal-title":"J. Park. Dis."},{"issue":"1\u20132","key":"10.1016\/j.phrs.2021.105661_bib122","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jns.2014.11.026","article-title":"Tanshinone IIA prevents the loss of nigrostriatal dopaminergic neurons by inhibiting NADPH oxidase and iNOS in the MPTP model of Parkinson\u2019s disease","volume":"348","author":"Ren","year":"2015","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.phrs.2021.105661_bib123","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jep.2015.01.042","article-title":"Tanshinone I selectively suppresses pro-inflammatory genes expression in activated microglia and prevents nigrostriatal dopaminergic neurodegeneration in a mouse model of Parkinson\u2019s disease","volume":"164","author":"Wang","year":"2015","journal-title":"J. Ethnopharmacol."},{"issue":"4","key":"10.1016\/j.phrs.2021.105661_bib124","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s11064-015-1751-6","article-title":"Neuroprotective effects of tanshinone i against 6-OHDA-induced oxidative stress in cellular and mouse model of parkinson\u2019s disease through upregulating Nrf2","volume":"41","author":"Jing","year":"2016","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.phrs.2021.105661_bib125","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.neuroscience.2015.06.030","article-title":"Tanshinone IIA protects dopaminergic neurons against 6-hydroxydopamine-induced neurotoxicity through miR-153\/NF-E2-related factor 2\/antioxidant response element signaling pathway","volume":"303","author":"Zhang","year":"2015","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.phrs.2021.105661_bib126","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1039\/C5FO00664C","article-title":"Inhibition effects of tanshinone on the aggregation of alpha-synuclein","volume":"7","author":"Ji","year":"2016","journal-title":"Food Funct."},{"issue":"17","key":"10.1016\/j.phrs.2021.105661_bib127","first-page":"s321","article-title":"Impact of diagnosis and early treatment on the course of multiple sclerosis","volume":"19","author":"Noyes","year":"2013","journal-title":"Am. J. Manag. Care"},{"issue":"9","key":"10.1016\/j.phrs.2021.105661_bib128","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.362","article-title":"An update on immunopathogenesis, diagnosis, and treatment of multiple sclerosis","volume":"5","author":"Garg","year":"2015","journal-title":"Brain Behav."},{"issue":"3","key":"10.1016\/j.phrs.2021.105661_bib129","first-page":"175","article-title":"Multiple sclerosis review","volume":"37","author":"Goldenberg","year":"2012","journal-title":"P T"},{"issue":"6","key":"10.1016\/j.phrs.2021.105661_bib130","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.neurol.2018.03.006","article-title":"Progress in understanding the pathophysiology of multiple sclerosis","volume":"174","author":"Zephir","year":"2018","journal-title":"Rev. Neurol. (Paris)"},{"issue":"4","key":"10.1016\/j.phrs.2021.105661_bib131","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/ana.24747","article-title":"Long-term evolution of multiple sclerosis disability in the treatment era","volume":"80","author":"University of California","year":"2016","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.phrs.2021.105661_bib132","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.20906.1","article-title":"Recent advances in understanding multiple sclerosis","volume":"8","author":"Stys","year":"2019","journal-title":"F1000 Research"},{"key":"10.1016\/j.phrs.2021.105661_bib133","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ejphar.2015.12.014","article-title":"Treatment with tanshinone IIA suppresses disruption of the blood-brain barrier and reduces expression of adhesion molecules and chemokines in experimental autoimmune encephalomyelitis","volume":"771","author":"Yang","year":"2016","journal-title":"Eur. J. Pharm."},{"issue":"2","key":"10.1016\/j.phrs.2021.105661_bib134","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.3892\/mmr.2016.5431","article-title":"Tanshinone IIA attenuates experimental autoimmune encephalomyelitis in rats","volume":"14","author":"Yan","year":"2016","journal-title":"Mol. Med. Rep."},{"issue":"2","key":"10.1016\/j.phrs.2021.105661_bib135","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1007\/s13311-019-00789-2","article-title":"Tanshinone IIA ameliorates CNS autoimmunity by promoting the differentiation of regulatory T cells","volume":"17","author":"Gong","year":"2020","journal-title":"Neurotherapeutics"},{"issue":"5","key":"10.1016\/j.phrs.2021.105661_bib136","first-page":"404","article-title":"[Dihydrotanshinone I (DHTS1) attenuates cuprizone-induced demyelination via regulating microglia polarization]","volume":"36","author":"Xu","year":"2020","journal-title":"Chin. J. Cell. Mol. Immunol."},{"issue":"4","key":"10.1016\/j.phrs.2021.105661_bib137","doi-asserted-by":"crossref","first-page":"250","DOI":"10.6061\/clinics\/2015(04)06","article-title":"Tanshinone IIA attenuates interleukin-17A-induced systemic sclerosis patient-derived dermal vascular smooth muscle cell activation via inhibition of the extracellular signal-regulated kinase signaling pathway","volume":"70","author":"Liu","year":"2015","journal-title":"Clin. (Sao Paulo)"},{"key":"10.1016\/j.phrs.2021.105661_bib138","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuroscience.2020.01.026","article-title":"Tanshinone IIA improves depression-like behavior in mice by activating the ERK-CREB-BDNF signaling pathway","volume":"430","author":"Lu","year":"2020","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.phrs.2021.105661_bib139","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0090-9556(25)07825-0","article-title":"The area under the curve of metabolites for drugs and metabolites cleared by the liver and extrahepatic organs. Its dependence on the administration route of precursor drug","volume":"13","author":"Klippert","year":"1985","journal-title":"Drug Metab. Dispos."},{"issue":"26","key":"10.1016\/j.phrs.2021.105661_bib140","doi-asserted-by":"crossref","first-page":"6243","DOI":"10.1523\/JNEUROSCI.0736-05.2005","article-title":"Mice with genetically altered glucocorticoid receptor expression show altered sensitivity for stress-induced depressive reactions","volume":"25","author":"Ridder","year":"2005","journal-title":"J. Neurosci."},{"issue":"11","key":"10.1016\/j.phrs.2021.105661_bib141","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1021\/cn400140e","article-title":"Tanshinone IIA exhibits anticonvulsant activity in zebrafish and mouse seizure models","volume":"4","author":"Buenafe","year":"2013","journal-title":"ACS Chem. Neurosci."},{"issue":"1","key":"10.1016\/j.phrs.2021.105661_bib142","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s12974-020-01874-6","article-title":"Tanshinone IIA alleviates brain damage in a mouse model of neuromyelitis optica spectrum disorder by inducing neutrophil apoptosis","volume":"17","author":"Gong","year":"2020","journal-title":"J. Neuroinflamm."},{"issue":"2","key":"10.1016\/j.phrs.2021.105661_bib143","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1517\/13543776.2013.743995","article-title":"Tanshinone II-A: new perspectives for old remedies","volume":"23","author":"Xu","year":"2013","journal-title":"Expert Opin. Ther. Pat."},{"issue":"8","key":"10.1016\/j.phrs.2021.105661_bib144","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1515\/revneuro-2016-0012","article-title":"Tanshinones and mental diseases: from chemistry to medicine","volume":"27","author":"Javed","year":"2016","journal-title":"Rev. Neurosci."},{"issue":"2","key":"10.1016\/j.phrs.2021.105661_bib145","first-page":"169","article-title":"Promising therapeutic effects of sodium tanshinone IIA sulfonate towards pulmonary arterial hypertension in patients","volume":"5","author":"Wang","year":"2013","journal-title":"J. Thorac. Dis."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661821002450?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661821002450?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T22:28:44Z","timestamp":1760912924000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661821002450"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":145,"alternative-id":["S1043661821002450"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2021.105661","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tanshinone IIA: A phytochemical as a promising drug candidate for neurodegenerative diseases","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2021.105661","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105661"}}